|
A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China CNBCLung Cancer Patients on Drug From China's Akeso Lived Longer Bloomberg.comASCO: Akeso's ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34% Fierce PharmaAkeso and Summit's ivonescimab extends survival in squamous cell lung cancer statnews.com
|
|
How aid cuts are hampering the frontline response to the Ebola crisis NPRThe U.S. Is Winging This Ebola Outbreak The AtlanticAs Ebola outbreak grows, Trump administration veers from previous government playbook statnews.comThese Researchers Would Be in Africa Fighting Ebola—but Trump Cut Their Funding WIREDFriday briefing: ?What do the cuts in aid mean for the fight against Ebola in the DRC?
|
|
NVIDIA's Upcoming N1x SoC Fails To Match Apple's 2023-Launching M3 Max Chip In Pre-Release Geekbench 6 Scores WccftechScoop: First Windows PCs powered by Nvidia chips to debut next week AxiosHow to watch Nvidia's Computex keynote The VergeFirst Windows PC powered by Nvidia chips to debut next week, Axios reports Reuters
|
|
French Open 2026: Iga Swiatek's exit means no previous champions left - who will seize chance? BBCMarta Kostyuk stuns Iga Swiatek, KO's last former French champ ESPNFrench Open Will Crown First-Time Men's and Women's Singles Champs Yahoo SportsKostyuk solves 4-time champ Swiatek, awaits Svitolina in all-Ukrainian Paris quarter WTA TennisIga Swiatek has an unhappy birthday after falling t
|
|
